These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


477 related items for PubMed ID: 9596551

  • 1. Diclofenac/misoprostol: the European clinical experience.
    McKenna F.
    J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551
    [Abstract] [Full Text] [Related]

  • 2. Arthrotec: a therapeutic option in the management of arthritis.
    Geis GS.
    Eur J Rheumatol Inflamm; 1993 May; 13(1):25-32. PubMed ID: 7821336
    [Abstract] [Full Text] [Related]

  • 3. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
    Bocanegra TS, Weaver AL, Tindall EA, Sikes DH, Ball JA, Wallemark CB, Geis GS, Fort JG.
    J Rheumatol; 1998 Aug; 25(8):1602-11. PubMed ID: 9712107
    [Abstract] [Full Text] [Related]

  • 4. [Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents].
    Delmas PD, Lambert R, Capron MH.
    Rev Rhum Ed Fr; 1994 Feb; 61(2):126-31. PubMed ID: 7920500
    [Abstract] [Full Text] [Related]

  • 5. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G, Lazzaroni M, Petrillo M.
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [Abstract] [Full Text] [Related]

  • 6. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients.
    Miglioli M, Bianchi Porro G, Vaira D, Menegatti M, Brunetti G, Petrillo M, Ardizzone S, Frizziero L, Montrone F, Grandinetti G.
    Am J Gastroenterol; 1996 Nov; 91(11):2367-71. PubMed ID: 8931419
    [Abstract] [Full Text] [Related]

  • 7. Diclofenac/misoprostol: novel findings and their clinical potential.
    Shield MJ.
    J Rheumatol Suppl; 1998 May; 51():31-41. PubMed ID: 9596552
    [Abstract] [Full Text] [Related]

  • 8. Misoprostol in the prevention of NSAID-induced gastric ulcer: a multicenter, double-blind, placebo-controlled trial.
    Roth SH.
    J Rheumatol Suppl; 1990 Feb; 20():20-4. PubMed ID: 2109073
    [Abstract] [Full Text] [Related]

  • 9. A double blind study comparing the efficacy and safety of enteric coated naproxen to naproxen in the management of NSAID intolerant patients with rheumatoid arthritis and osteoarthritis. Naproxen EC Study Group.
    Caldwell JR, Roth SH.
    J Rheumatol; 1994 Apr; 21(4):689-95. PubMed ID: 8035394
    [Abstract] [Full Text] [Related]

  • 10. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
    Goldstein JL, Correa P, Zhao WW, Burr AM, Hubbard RC, Verburg KM, Geis GS.
    Am J Gastroenterol; 2001 Apr; 96(4):1019-27. PubMed ID: 11316141
    [Abstract] [Full Text] [Related]

  • 11. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee.
    Pincus T, Koch GG, Sokka T, Lefkowith J, Wolfe F, Jordan JM, Luta G, Callahan LF, Wang X, Schwartz T, Abramson SB, Caldwell JR, Harrell RA, Kremer JM, Lautzenheiser RL, Markenson JA, Schnitzer TJ, Weaver A, Cummins P, Wilson A, Morant S, Fort J.
    Arthritis Rheum; 2001 Jul; 44(7):1587-98. PubMed ID: 11465710
    [Abstract] [Full Text] [Related]

  • 12. Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis.
    Melo Gomes JA, Roth SH, Zeeh J, Bruyn GA, Woods EM, Geis GS.
    Ann Rheum Dis; 1993 Dec; 52(12):881-5. PubMed ID: 8311540
    [Abstract] [Full Text] [Related]

  • 13. Prevention of nonsteroidal anti-inflammatory drug-induced gastropathy: clinical and economic implications of a single-tablet formulation of diclofenac/misoprostol.
    Goldstein JL, Larson LR, Yamashita BD.
    Am J Manag Care; 1998 May; 4(5):687-97. PubMed ID: 10179922
    [Abstract] [Full Text] [Related]

  • 14. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
    Rabeneck L, Goldstein JL, Vu A, Mayne TJ, Rublee DA.
    Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
    [Abstract] [Full Text] [Related]

  • 15. Prevention of gastrointestinal complications associated with nonsteroidal antiinflammatory drugs.
    Agrawal NM, Aziz K.
    J Rheumatol Suppl; 1998 May; 51():17-20. PubMed ID: 9596550
    [Abstract] [Full Text] [Related]

  • 16. [Prevention of NSAID induced gastroduodenal ulcers].
    Hansen JM, Bytzer P.
    Ugeskr Laeger; 2001 Oct 29; 163(44):6103-5. PubMed ID: 11715151
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.
    Geis GS, Stead H, Wallemark CB, Nicholson PA.
    J Rheumatol Suppl; 1991 Mar 29; 28():11-4. PubMed ID: 1903808
    [Abstract] [Full Text] [Related]

  • 18. The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis.
    Pope JE, Prashker M, Anderson J.
    J Rheumatol; 2004 Jan 29; 31(1):140-9. PubMed ID: 14705233
    [Abstract] [Full Text] [Related]

  • 19. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF, Pan S.
    Clin Ther; 2006 Mar 29; 28(3):340-51. PubMed ID: 16750449
    [Abstract] [Full Text] [Related]

  • 20. Diclofenac/misoprostol. A review of its pharmacology and therapeutic efficacy in painful inflammatory conditions.
    Davis R, Yarker YE, Goa KL.
    Drugs Aging; 1995 Nov 29; 7(5):372-93. PubMed ID: 8573992
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.